Upper Airway Obstruction/Infections

advertisement
Good
Morning!
Semantic Qualifiers
Symptoms
Acute /subacute
Chronic
Localized
Diffuse
Single
Multiple
Static
Progressive
Constant
Intermittent
Single Episode
Recurrent
Abrupt
Gradual
Severe
Mild
Painful
Nonpainful
Bilious
Nonbilious
Sharp/Stabbing
Dull/Vague
Problem Characteristics
Ill-appearing/
Toxic
Well-appearing/
Non-toxic
Localized problem
Systemic problem
Acquired
Congenital
New problem
Recurrence of old
problem
• Harsh, high-pitched
resp sound
• Usually inspiratory
Stridor
– But can be biphasic
Site of
Pathology
Respiratory
Rate
• Cause by turbulent flow
• Sign of upper airway
obstruction
• NOT a diagnosis
Retractions
Audible Sounds
Extrathoracic
airway
Stridor
Intrathoracic
extrapulmonary
Wheezing
Intrathoracic
intrapulmonary
Wheezing
Alveolar
interstitial
Grunting
Stridor
• Viral croup
• Foreign body
• Noninfectious croup
• Retropharyngeal abscess
• Epiglottitis
• Peritonsillar abscess
• Bacterial tracheitis
• Angioedema
• Extraluminal compression
• Caustic ingestion
• Intraluminal obstruction
from masses
• Vocal cord dysfunction
“Croup”
• Group of conditions
– Acute and infectious causes of upper airway
inflammation
• Upper airway of children
Laryngotracheitis
• = most common “Croup” illness
– Laryngotracheitis vs.
Laryngotracheobronchitis/pneumonitis
• Predisposing Factors
–
–
–
–
Between age 3 months and 5 yrs
Peak in 2nd year of life
M>F
Can occur anytime of year but peaks in late fall and
winter
– Preceding URI illness
Laryngotracheitis
• Pathophysiology
– Inflammation involving the vocal cords and
structures inferior to the cords
Laryngotracheitis
• Pathophysiology
– Viral etiology is most common
• Parainfluenza viruses (type 1, 2, and 3) ~ 75% of cases
• Influenza A
– Associated with SEVERE disease
•
•
•
•
Influenza B
Adenovirus
RSV
Measles
– Mycoplama pneumoniae rarely isolated
Laryngotracheitis
• Clinical Presentation**
– URI symptoms for 1-3 days prior to signs of upper
airway obstruction
• Rhinorrhea, pharyngitis, mild cough, low-grade fever
– Characteristic “barking” cough, “seal-like”
– Hoarseness
– Inspiratory stridor
– +/- fever
Laryngotracheitis
• Clinical Presentation**
– Symptoms characteristically worse at night
– Agitation and crying aggravate symptoms
– Varying degrees of respiratory distress on exam
– Should not be hypoxic – this is a sign that
complete airway obstruction is imminent
Laryngotracheitis
• Diagnosis
– Clinical
– Xrays
• “Steeple sign” in
AP view
• Do not correlate
with disease severity
• Can help distinguish
from other causes
Laryngotracheitis
• Treatment**
– Most patients managed
as outpatients
– Cool mist??
• Not proven in literature, but used since the 1900’s
• If bronchospasm present, can worsen with cool mist
– Antibiotics not indicated in viral croup
Laryngotracheitis
• Treatment**
– Corticosteroids
• Action: decrease laryngeal mucosal edema
• Effective in reducing hospitalization rates, shorter
hospital stays, reduced need for subsequent
interventions
• Dose: 0.6mg/kg single dose DEXAMETHASONE (max
16mg)
– PO/IM Decadron both effective
– Clincal improvement 6 hours after dose
– Prednisolone less effective than Dexamethasone
Laryngotracheitis
• Treatment**
– Nebulized racemic epinephrine (Vaponeb)
• For moderate to severe croup
• Action: decrease laryngeal mucosal edema
• Dose: 0.25ml-0.5ml of 2.25% racemic epi in 3ml of NS
nebulized
–
–
–
–
Onset of relief 10-30min
Duration of activity <2-3 hours
Can repeat q20 min
Monitor for symptoms once
the Vaponeb activity duration
is over (rebound?), generally
3-4 hrs after a treatment
• Use caustiously in patients with tachycardia, and heart
conditions such as TOF or ventricular outlet obstruction
Laryngotracheitis
• Indications for hospitalization with croup
– Progressive stridor
– Severe stridor at rest
– Respiratory distress
– Hypoxia/cyanosis
– Depressed mental status
– Poor oral intake
– Need for reliable observation
Laryngotracheobronchitis/pneumonitis
• More severe form of croup
• Considered an extension of laryngotracheitis
associated with bacterial superinfection
– Occurs 5-7 days into the clinical course
– New onset fever
– Worsening clinical symptoms, toxic
– Increased work of breathing
• Signs of both upper and lower airway obstruction
• Requires empiric antibiotics
Feature
Acute
Spasmodic
Laryngotracheitis
Croup
Prodrome
URI
Mean Age
3 mo - 5 yr
Onset
gradual
Fever
variable
Hoarseness,
barking cough
Inspiratory stridor
Yes
Yes:
minimal to severe
Dysphagia
No
Toxic appearance
No
Etiology
Viral
X-ray findings
Steeple sign
Treatment
cool mist,
racemic epi neb,
dexamethasone
Epiglottitis
Bacterial
Tracheitis
Noninfectious Croup
• “Spasmodic” croup**
– Most often children 1 to 3 yrs
– Pathogenesis unknown – possible allergic etiology
– Clinically similar to croup but without the viral
prodrome or fever
– Most common in the evening
– Sudden onset, preceded by mild cough or hoarseness
– Episode of characteristic coughing, stridor and
respiratory distress, anxious
– Severity improves over hours and can have repeat
episodes x1-2 more nights
Feature
Acute
Spasmodic
Laryngotracheitis
Croup
Prodrome
URI
none or minimal
coryza
Mean Age
3 mo - 5 yr
1 to 3 yr
Onset
gradual
sudden
Fever
variable
no
Inspiratory stridor
Yes
Yes:
minimal to severe
Yes
Yes: usually
moderate
Dysphagia
No
No
Toxic appearance
No
No
Etiology
Viral
Noninfectious
X-ray findings
Steeple sign
---
Treatment
cool mist,
racemic epi neb,
dexamethasone
cool mist
Hoarseness,
barking cough
Epiglottitis
Bacterial
Tracheitis
Epiglottitis
• Predisposing Factors
– Typical age of patients 2 to 4 yrs
– Unimmunized
Epiglottitis
• Pathophysiology
– Prevaccine, most common cause:
• Haemophilus influenzae type B
– Now, larger number of cases in vaccinated
patients due to:
• Streptococcus pyogenes
• Streptococcus pneumoniae
• Staphylococcus aureus
Epiglottitis
• Pathophysiology
– Inflammation of
epiglottis
– Degree of
inflammation leads to
degree of obstruction
of airway
Epiglottitis
• Clinical Presentation
– Acute
– High fever
– Sore throat
– Dyspnea
– Rapidly progressing respiratory obstruction
• Can be within hours – become toxic, difficulty
swallowing, labored breathing
Epiglottitis
• Clinical Presentation
– Drooling
– Holding neck in hyperextended position
– Tripod position
– Stridor is a late finding!
– Not usually associated with a cough
Epiglottitis
• Diagnosis
– Visualization via laryngoscopy
• In controlled environment
Epiglottitis
• Diagnosis
– Xrays
• “Thumb sign” in
lateral view
Epiglottitis
• Treatment**
– Careful on exam**
• Avoid anxiety-provoking procedures (labs/IV), avoid
placing patient supine or direct inspection of oral cavity
• To prevent acute airway obstruction
– Medical emergency
– Placement of artificial airway in controlled setting
• Mortality ~6% without airway vs. <1% with airway
– Oxygen via mask until artificial airway
• As long as mask doesn’t cause agitation
Epiglottitis
• Treatment**
– Antibiotics**
•
•
•
•
Ceftriaxone
Cefotaxime
Meropenem
Obtain cultures from blood, epiglottic surface, and if
needed from CSF (after obtain airway)
• Treat with at least 7-10 antibiotics, but usually patient
improves after 2-3 days
Epiglottitis
• Rifampin prophylaxis indicated for:
– Any household contacts <48 months old and
incompletely immunized
– Any household contacts <12 months old and has
not received primary vaccination series
– Any immunocompromised child in the household
Feature
Acute
Spasmodic
Laryngotracheitis
Croup
Epiglottitis
Prodrome
URI
none or minimal
coryza
Mean Age
3 mo - 5 yr
1 to 3 yr
2 to 4 yr (range 1 to 8 yr)
Onset
gradual
sudden
rapid
Fever
variable
no
High
Inspiratory stridor
Yes
Yes:
minimal to severe
Yes
Yes: usually
moderate
No
Yes:
moderate to severe
Dysphagia
No
No
Yes
Toxic appearance
No
No
Yes
Hoarseness,
barking cough
none or mild URI
Etiology
Viral
Noninfectious
Bacterial: Hib, Strep,
S. aureus
X-ray findings
Steeple sign
---
Thumb sign
Treatment
cool mist,
racemic epi neb,
dexamethasone
cool mist
Intubation,
Ceftriaxone, or Cefotaxime,
or Meropenem
Bacterial
Tracheitis
Bacterial Tracheitis
• Predisposing Factors
– Mean age 5 to 7 yrs
– M=F
– Preceding viral respiratory
infection
• Bacterial complication of
croup
– More common than epiglottitis
in vaccinated patients
Bacterial Tracheitis
• Pathophysiology
– Mucosal swelling at the
level of the of the cricoid
cartilage
– Complicated by copius, thick, purulent secretions,
sometimes pseudomembranes
– Most common pathogen: S. aureus
• Other organisms: Moraxella catarrhalis, nontype H.
influenzae, and anaerobic organisms
Bacterial Tracheitis
• Clinical Presentation**
– Preceding croup illness with cough
– Then develops high fever and toxic-appearance
– Differs from epiglottitis
• Patient can lie down, does not drool, no dysphagia
– Differs from croup
• More toxic, does not respond to racemic epi
Bacterial Tracheitis
• Diagnosis
– Clinical picture
• Toxic + absence
of classic epiglottitis
– Xrays
• Not necessary
• Findings of irregular
lining of the trachea
due to pseudomembranes
• Can have “steeple sign”
Bacterial Tracheitis
• Treatment**
– Artificial airway required in ~50-60% of patients
– More likely to require intubation if younger
– Antibiotics
• Including appropriate Staph coverage
• Vanc + 3rd gen Cephalosporin = empiric coverage
Feature
Acute
Spasmodic
Laryngotracheitis
Croup
Epiglottitis
Bacterial
Tracheitis
none or mild URI
URI/croup
Prodrome
URI
none or minimal
coryza
Mean Age
3 mo - 5 yr
1 to 3 yr
2 to 4 yr (range 1 to 8 yr)
5 yr to 7 yr
Onset
gradual
sudden
rapid
acute after prodrome
Fever
variable
no
High
High
Hoarseness,
barking cough
Inspiratory stridor
Yes
Yes:
minimal to severe
Yes
Yes: usually
moderate
No
Yes:
moderate to severe
Variable, with
prodrome
Yes:
Variable
Dysphagia
No
No
Yes
No
Toxic appearance
No
No
Yes
Yes
Bacterial: S. aureus
Etiology
Viral
Noninfectious
Bacterial: Hib, Strep,
S. aureus
X-ray findings
Steeple sign
---
Thumb sign
Irregular tracheal lining
Intubation,
Ceftriaxone, or Cefotaxime,
or Meropenem
Often intubation
required,
Vancomycin and 3rd
gen Cephalosporin
Treatment
cool mist,
racemic epi neb,
dexamethasone
cool mist
Noon
Conference!
Download